CBDN — Cbd Global Sciences Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual cashflow statement for Cbd Global Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -8.96 | -8.93 | -5.25 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 5.67 | 6.77 | 3.14 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.16 | 0.658 | 0.909 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -1.94 | -1.34 | -1.14 |
| Capital Expenditures | -0.21 | — | -0.003 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 0.055 | 0.224 |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Cash from Investing Activities | -0.21 | 0.055 | 0.221 |
| Financing Cash Flow Items | 0.329 | 0.98 | 1.19 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.85 | 1.26 | 1.01 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.299 | -0.021 | 0.093 |